RSA board to receive PwC review on Ireland irregularities

Risk magnifying glass

Insurer confirms £200m cash injection into its Irish business.

The RSA board will today receive the PwC review on the claims and finance issues uncovered in its Irish business.

In a London Stock Exchange announcement the insurer insisted that it is "confident" in its view that the financial and claims irregularities identified in November 2013 were "isolated" to Ireland.

And it confirmed that it was forced to inject a total of £200m into its Irish business, consisting of two doses of £72m and £128m respectively.

The "key findings" of the report are set to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Meet the MGA: Kayzen Specialty

Kayzen Specialty founder and CEO Charles Boorman explains to Jonathan Swift his plans for the MGA to be a go-to market for financial lines through continuous improvement across its three pillars of broker-centric, underwriter-fronted and tech-focused.

i-Wonder delivers on fast food

i-Wonder, provider of niche insurance comparison website solutions, has confirmed the adoption of its offering for the UK fast food delivery sector by “one of” the UK’s main aggregators, Insurance Age can reveal.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: